Aug 6 (Reuters) - Imugene Ltd IMU.AX :
* RECEIVES GUIDANCE FROM US FDA ON DEVELOPMENT PATHWAY FOR ONCOLYTIC VIROTHERAPY VAXINA
* REGULATORY PLANNING INITIATED FOR CONDUCTING TRIAL IN US AND AUSTRALIA
Aug 6 (Reuters) - Imugene Ltd IMU.AX :
* RECEIVES GUIDANCE FROM US FDA ON DEVELOPMENT PATHWAY FOR ONCOLYTIC VIROTHERAPY VAXINA
* REGULATORY PLANNING INITIATED FOR CONDUCTING TRIAL IN US AND AUSTRALIA